Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STudio Osservazionale Sull'Efficacia, Sicurezza e tollerabilità di Atogepant in Pazienti Real Life Affetti da Emicrania in Italia (Studio STAR)

NCT06414044 is registered in ClinicalTrials.gov with University of Florence as lead sponsor.

NCT NCT06414044
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06414044 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STudio Osservazionale Sull'Efficacia, Sicurezza e tollerabilità di Atogepant in Pazienti Real Life Affetti da Emicrania in Italia (Studio STAR)
Lead sponsor
University of Florence
Phase
Observational
Overall status
Active, not recruiting
Start date
May 9, 2024
Completion date
April 30, 2026
Enrollment
500 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic migraine, migraine, migraine with aura, migraine without aura